Merck KGaA | ApexOnco - Clinical Trials news and analysis

“The insights provided by the analysts are great”

Director New Product Planning

Morphosys

Click here for more information

Regulatory

15 April 2026

Sanofi and Pfizer get another conjugate blow

3 July 2025

M&A analysis: signs of life emerge

Some big deals in the second quarter have raised hopes that takeouts are back.

Trial results

6 May 2025

Mersana goes all in on B7-H4

Deals

28 April 2025

German Merck plays hardball to get SpringWorks

Data insights

7 April 2025

Haihe takes on Orpathys in China

Trial results

1 April 2025

Merck KGaA’s Inspirna bet goes south

Deals

28 March 2025

German Merck makes SpringWorks holders squirm

Regulatory

3 March 2025

FDA red and green lights: February 2025

Adcetris bags its eighth approval, while SpringWorks and Ono also feature.

Regulatory

17 February 2025

Ono takes on Daiichi in tenosynovial giant cell tumour

Regulatory

12 February 2025

SpringWorks gets an early second approval

Subscribe to Merck KGaA

Sanofi and Pfizer get another conjugate blow

M&A analysis: signs of life emerge

Mersana goes all in on B7-H4

German Merck plays hardball to get SpringWorks

Haihe takes on Orpathys in China

Merck KGaA’s Inspirna bet goes south

German Merck makes SpringWorks holders squirm

FDA red and green lights: February 2025

Ono takes on Daiichi in tenosynovial giant cell tumour

SpringWorks gets an early second approval

Recent Quick take

Most Popular